CIK: 0001779763 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $557,758 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ICLR | ICON PLC | 225,000 | $43,706 | 7.8% | $213.87 | -7.3% | SHS | G4705A100 |
| CRL | CHARLES RIV LABS INTL INC | 200,000 | $43,580 | 7.8% | $215.88 | +1.2% | COM | 159864107 |
| UHS | UNIVERSAL HLTH SVCS INC | 300,000 | $42,267 | 7.6% | $116.28 | 0.0% | CL B | 913903100 |
| — | COOPER COS INC | 123,000 | $40,672 | 7.3% | $330.67 | — | COM NEW | 216648402 |
| SGRY | SURGERY PARTNERS INC | 1,280,000 | $35,661 | 6.4% | $31.85 | -16.9% | COM | 86881A100 |
| GILD | GILEAD SCIENCES INC | 373,569 | $32,071 | 5.7% | $70.79 | 0.0% | COM | 375558103 |
| SNY | SANOFI | 650,000 | $31,480 | 5.6% | $38.02 | — | SPONSORED ADR | 80105N105 |
| RGEN | REPLIGEN CORP | 178,000 | $30,137 | 5.4% | $168.34 | +7.8% | COM | 759916109 |
| BSX | BOSTON SCIENTIFIC CORP | 600,000 | $27,762 | 5.0% | $40.71 | +6.4% | COM | 101137107 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 407,074 | $26,724 | 4.8% | $62.85 | -3.9% | COM | G31249108 |
| INSP | INSPIRE MED SYS INC | 80,000 | $20,150 | 3.6% | $199.42 | +6.9% | COM | 457730109 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 71,576 | $19,905 | 3.6% | $252.44 | 0.0% | COM | 91307C102 |
| CI | CIGNA CORP NEW | 60,000 | $19,880 | 3.6% | $251.70 | +18.7% | COM | 125523100 |
| ISRG | INTUITIVE SURGICAL INC | 70,000 | $18,575 | 3.3% | $243.83 | 0.0% | COM NEW | 46120E602 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 200,000 | $16,464 | 3.0% | $62.12 | +32.7% | COM | 00404A109 |
| SRPT | SAREPTA THERAPEUTICS INC | 107,749 | $13,962 | 2.5% | $100.79 | +15.0% | COM | 803607100 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,700,000 | $13,906 | 2.5% | $5.74 | +50.2% | COM | 69404D108 |
| DXCM | DEXCOM INC | 120,080 | $13,598 | 2.4% | $93.80 | +17.0% | COM | 252131107 |
| — | INARI MED INC | 190,000 | $12,076 | 2.2% | $72.64 | — | COM | 45332Y109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 100,089 | $11,955 | 2.1% | $92.44 | +26.7% | COM | 64125C109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 370,294 | $9,424 | 1.7% | $23.32 | 0.0% | COM | 87164F105 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 240,240 | $8,877 | 1.6% | $35.49 | 0.0% | COM | 03237H101 |
| — | PROMETHEUS BIOSCIENCES INC | 75,000 | $8,250 | 1.5% | $110.00 | — | COM | 74349U108 |
| MASS | 908 DEVICES INC | 874,731 | $6,665 | 1.2% | $17.26 | -29.9% | COM | 65443P102 |
| — | KARYOPHARM THERAPEUTICS INC | 1,926,782 | $6,551 | 1.2% | $3.40 | — | COM | 48576U106 |
| STXS | STEREOTAXIS INC | 1,671,109 | $3,459 | 0.6% | $7.57 | -74.2% | COM NEW | 85916J409 |